New solution accelerates payments to patients participating in a clinical trial, improving experience and access Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions ...
A bill called the Risky Research Review Act is currently under consideration in the U.S. Senate, which could finally require independent oversight in determining whether such risks are worth taking.